Prof. Dr. Fred van Eenennaam joins the Microeconomics of Competitiveness Affiliate Network Hall of Fame
We are delighted to announce that Prof. Dr. Fred van Eenennaam, partner of The Decision Group, has been put in the limelight by Prof. Dr. Michael Porter. Because of his contribution to the pragmatics of and research in the competitiveness of clusters, as well as his extensive involvement in the worldwide MOC network, Prof. Dr. Fred van Eenennaam is now included in the Microeconomics of Competitiveness Affiliate Network Hall of Fame. We are proud of this unexpected honour, and we see it as an encouragement to continue to offer our expertise to all who can use it to their advantage.
Visit our dedicated website to learn more on Competitiveness & Clusters!
The Netherlands Institute for Competitiveness
Furthermore, we are pleased and excited to announce that in December 2012, we have launched the Netherlands Institute for Competitiveness. The Institute could not have been established without the help from our international academic colleagues. It is the logical consequence of the experiences in the past. The center combines the international network of cluster organizations with academic and pragmatic expertise on international business. The aim of the Netherlands Institute for Competitiveness is to provide expertise, access and knowledge to 1) companies that wish to build their international business and 2) academic institutes that wish to increase their knowledge.
We invite you to take a look at our website.Continue reading
The first outcome measures and results for several medical conditions in cardiology are known! Download the Meetbaar Beter books by clicking the seperate books for the Heart Centers of Catharina and St Antonius hospitals.
Meetbaar Beter – Value Based Health Care
With Meetbaar Beter, The Decision Group, together with the cardiologists and cardio thoracic surgeons of Catherina and St Antonius Nieuwegein Hospitals developed patient relevant medical Outcome Measures for 5 medical conditions in cardiology and new medical conditions are being explored.
Meetbaar Beter is based on the concepts of Value Based Health Care. The outcome measures are developed from the perspective of the patient. What are the value adding activities for the patient and how can value be measured? Learn more and visit the dedicated website: www.vbhc.nl
Learn More? Masterclass Outcome Measures – October 30
Learn how Outcome Measures can be developed and implemented during the Masterclass Outcome Measures of October 30, 2012 or March 6th, 2012. Sign up or send an email to Niels van Gorp for more information. Best practices in the field of clinical management are discussed at the Clinical Management Workshop Series based on Harvard Business Cases. Discover how the Cleveland Clinic implemented outcome measures or how Intermountain optimized its processes. Visit the website for more information.Continue reading
The first outcome measures and results for several medical conditions in cardiology are known! More than 250 visitors attended the impressive symposium in the Ruwenberg St. Michielsgestel on October 12, 2012. Prof. Dr. Fred van Eenennaam, partner of The Decision Group, led the afternoon, and told how Value Based Health Care works and how the outcome measures have been established.
The outcome measures are developed from the perspective of the patient. What are the value adding activities for the patient and how can value be measured? Maarten Koomans, partner of The Decision Group and chairman of Value Based Health Care Center Europe explains: “The results are for the total care of the patient. Not limited to the hospital and not only for the treatment by the medical specialist.” This is underlined by Dennis van Veghel, project leader Meetbaar Beter. “We give the patient insights into what he or she may expect of us”.
The patient organization Heart & Vascular Group was enthusiastic about the approach. It is: “durven, doen en doorpakken“. The Consumentenbond added: “There is widespread support created and it is started by the medical specialist“. The cardiologists and cardio thoracic surgeons have worked with The Decision Group to develop outcome measures. “It’s works like a mirror,” admits Jacques Koolen cardiologist Catharina Ziekenhuis. Through intensive collaboration we learned from each other, and the dialogue was based on quality.
Several websites (nu.nl, skipr, zorgvisie), radio (radio 1) and television (including nos-journal) paid attention to the symposium. Achmea Senior Medical Advisor Ben Crul complimented Meetbaar Beter with its speed and scientific argumentation. Joel Gijzen Director Zorg Inkoop CZ stressed that attention should be paid on improving the care process with outcome measures as a clear internal quality control. Comparing with other hospitals is secondary. VGZ Maarten van der Vorst shared the view of Achmea and CZ and was particularly pleased with the acceptance of the field.
Meanwhile, four hospitals indicated to participate in Meetbaar Beter. Veronique Esman-Peeters Director Curatieve Zorg hopes that people will cooperate with Meetbaar Beter. She is very happy with the speed of the project.
Learn how Outcome Measures can be developed and implemented during the Masterclass Outcome Measures of October 30, 2012. Sign up or send an email to Niels van Gorp for more information. Best practices in the field of clinical management are discussed at the Clinical Management Workshop Series based on Harvard Business Cases. Discover how the Cleveland Clinic implemented outcome measures or how Intermountain optimized its processes. Visit the website for more information.Continue reading
At the successful event on The Value of Diagnostics of June 5th 2012, The Decision Group Framework was launched. This decision framework for diagnostics will help organizations to asses the value of diagnostics. The framework and methodology received very positive replies from the audience:
- The event was very usefull and inspiring. It gave me a new vision on how to interpret costs and value. – Medical specialist
- The Decision Framework is innovative and can result in product improvement. The Value of Diagnostics is the ‘new thinking’ – Director of Life Sciences company
- The Decision Group succeeded to open a new discussion on diagnostics, via a differen point of view and a practical approach’ – Head Clinical Chemistry
A large variety of stakeholder groups were present at the event. A sample of the companies and organisations represented:
Borstkankervereniging Nederland IKNL Check-Points B.V. Isala Klinieken Citeq Health Products Ned. Ver. voor Radiologie De Friesland Zorgverzekeraar Nucletron Diaconessenhuis Meppel NVOG Distrilab BV Philips Healthcare Benelux E-nose Radboud University Nijmege MC Erasmus MC Roche Diagnostics Nederland Flevoziekenhuis Saltro Forbion Capital Partners Saxenburgh groep GE Healthcare St Lucas Andreas Ziekenhuis Glaxo Smith Kline Virtual Proteins BV Haga Teaching Hospital Vu University Medical Center Hycult Biotech
During the discussion it became clear that this new approach brings high added value for the different stakeholders. Actions to learn more:
- Download the stakeholderflyers to learn more about the implications, the project possibilities and the Decision Group Framework.
(Stakeholder Flyer Care&Cure, Stakeholder Flyer Industry&Investors, Stakeholder Flyer Goverment, Insurers and Patients).
- Visit our new website on a regular basis for more in depth information, the presentations, and news and updates.
- Contact Kim Bruheim, Msc. (email@example.com) for questions or suggestions.
Executive Education Programs Healthcare by affiliate The Decision Institute:Continue reading
– Clinical Management Workshop Series
– Masterclasses Value Based Health Care
– Strategy & Goverancence Excellence Series
– Masterclass Healthcare ‘New&Improved’
Our befriended affiliates at Harvard Business School; Prof. R.S. Kaplan and Prof. M.E. Porter published a new article in the New York Times. “Why Medical Bills Are a Mystery”.(Click to download) The piece sheds light on the broken costing practices in health care and the opportunities that arise from accurately measuring the costs of resources used at the medical condition level. Combining improved costing practices with rigorous measurement of patient outcomes allows for targeted process redesign and care delivery improvements, which yield substantial savings and may be the only way to truly “bend the curve” of rising health care costs.
The Decision Group hopes you enjoy the article and that it engenders discussion of these issues at your organization.
Masterclass Health Costing
The Decision Group and The Decision Institute work as the European partner of prof. Porter to roll out the principles of Value Based Healthcare, of which Health Costing forms an integral part. Our new Masterclass Health Costing is now available to help you and your organization with a practical approach towards Health Costing and decisionmaking on costs. For more information on our open or inhouse Masterclass Health Costing or to run a pilot program, please contact Barbara Schooneveldt at firstname.lastname@example.org. For more information on the other masterclasses in the Value Based Healthcare series, download the brochure or visit our healthcare website.
See also:Continue reading
‘ Measuring the quality of healthcare: principles and challenges’ was the title of the symposium Aantoonbaar Beter organized by the Nederlandse Federatie van Universitair Medische Centra (NFU) and Gezondheidsraad on April 5, 2012. The interesting speakers and enthusiastic participants discussed the relevance and examples of outcome measures. Partcipating stakeholders all endorsed the relevance of outcome measures – the guiding the principle of Value-Based Healthcare. This is truly a step in the right direction. But how to get Outcome Measurement started?
The Decision Group & Value-Based Healthcare
During the symposium many ideas were brought about on Outcome Measures. But ideas are not enough. It is important to convert these ideas into a practical approach for implementation. The Decision Group helps to implement Value-Based Healthcare and our Outcome Measures methodology in your organization. We are Prof. Michael Porter’s European partner to roll out Value Based Healthcare in Europe and The Netherlands. Currently, The Decision Group is running various pilot projects. Our flagship project “Meetbaar Beter” sets and collects Outcome Measures for the heart centers of Catharina and Sint Antonius Hospitals. For more information about The Decision Group and Outcomes, you can visit our special website.
See alsoContinue reading
Prof. Dr. Fred van Eenennaam, partner of The Decision Group and Dirk Hogervorst, of FloraHolland, acted as case protagonists in Prof. Michael Porters’s teaching of the Dutch Flower Cluster case. The topics discussed were on strategies in clusters and competitiveness in relation to the Dutch Economy. The Dutch Flower Cluster Case, the succes story of the flower industry in The Netherlands, is a Harvard Business School case written by Prof. Porter, Dr. Ramirez-Vallejo and Prof. Dr. Fred van Eenennaam with the help of Dirk Hogervorst of FloraHolland. The flower industry is important for the Dutch economy and part of the topsector horticulture & propagation materials. With topsectors, the Dutch government has set a focus on core clusters for innovation policy.
The Decision Group and Clusters and Competitiveness
The Decision Group has extensive expertise in competitiveness, clusters and associations. Our work in clusters has academic grounding through Prof. Dr. Fred van Eenennaam’s connects to Harvard’s Microeconomics of Competitiveness course and international network. The Decision Group helps monitoring clusters success, develops strategic plans and scenario’s, and is active in association management. For 4 years now, The Decision Group develops a yearly Outlook for the Dutch Life Science Health cluster, monitoring performance & progress with recommendations for future improvement. The Decision Group just started development of the Dutch Life Sciences & Health Outlook 2013.
The Decision Group Strategy Consulting on Competitiveness & Clusters:
– Consulting on Competitiveness & Clusters
The Dutch Life Sciences Outlook:Continue reading
– Outlook 2012
Prof. Porter emphasized our fine relationship by introducing the Decision Group as “our (Harvard Business School. red.) partner in unrolling the concepts of Value Based Healthcare in the Netherlands and Europe.”
Value Based Healthcare
During the Strategy for Healthcare Delivery Workshop, the latest insights were shared on Value Based Healthcare. Business cases of best practice hospitals were discussed with subjects like Time-driven Activity Based Costing, Outcome Measures, Integrated Practice Units and Network Strategy. Prof. Kaplan, the world renowned expert on accounting, was a keynote speakers during the workshop.
The Decision Group has expertise on all Value Based Healthcare topics and integrates the best practices in our Healthcare projects. The “flagship project” is the definition of Outcome Measures for both Catharina Hospital and Antonius Hospital. In our Clinical Management Workshop Series the latest insights on Value Based Healthcare are shared with participating stakeholders in Dutch Healthcare.
The Decision Group Healthcare Consulting:Continue reading
– Healthcare Consulting
The Decision Group & Harvard Business School Professors to further cooperation on Corporate Governance
During the Maximize Your Board’s Potential™ seminar of January 23rd-26th 2012, partners of The Decision Group, Prof. Dr. Fred van Eenennaam and ir. Maarten Koomans, discussed further cooperation with Harvard Business School professors Jay Lorsch and Krishna Palepu, who are world renowned for their work on Corporate Governance. Among other initiatives and coproductions, a new (3rd) Maximize Your Board’s Potential™ seminar, organized in collaboration with Intrabond Capital, has been planned for March 18th-21st 2013 (date subject to change).
The Decision Group and Corporate Governance
Over the years The Decision Group has built extensive expertise on Corporate Governance & Board Programs. The Decision Group’s partner Prof. Dr. Fred van Eenennaam is a renowned expert on Corporate Governance and has built numerous board programs, like NCD Nyenrode Commissarissencyclus, New Board Program and the New CFO (now at Erasmus’ ESAA). The Decision Group is affiliated to a large number of universities and business schools and has links with professors all over the world.
The Decision Group also partners with Harvard Business School prof. Michael Porter to roll out Value Based Healthcare in Europe and The Netherlands. Prof. van Eenennaam is affiliated to prof. Porters Microeconomics of Competitiveness network of HBS Institute for Strategy & Competitiveness
See also:Continue reading
Corporate Goverance & Board Programs
– Maximize Your Board’s Potential – 3rd edition
– Maximize Your Board’s Potential – 2nd edition
– Maximize Your Board’s Potential – 1st edition
– The new CFO
– NCD Commissarissencyclus
– New Board Program
– Strategic Leadership Program
– Affiliations and memberships
– Affiliate Intrabond Capital
Consulting Corporate Goverance
– The Decision Group – Strategy Consulting for Boards
– Foundations of Corporate Governance
From our international work on outcome measures, we would like to bring your attention to this (click to read the full article) interesting study by USA today of Medicare data:
The focus on relevant outcome measures is a key part of improving health care delivery (see also Quality-based selection of hospitals for Transcatheter Heart Valve Interventions and the symposium we organized about the results of this study ). Process measures, structure measures, different types of cost measures, quality measures, medically relevant patient outcome measures, patient reported outcome measures, health economic measures and patient perception and satisfaction measures have all been intertwined. This strongly obscures effective decision making in healthcare. In our work and with the collaborations with Prof Porter (Outcome Measures project ) and others the opion is that medically relevant patient outcomes should be the yard stick for decision making.
Whether patient perception and satisfaction measures (client measures) can be used as valid indicators to get insight in the quality of health outcomes has been debated for some time now. The study of the Medicare data suggests at least to take extreme care in assuming a relationship.
Please feel free to contact us personally to discuss this topic and the possible opportunities for your organization.
ir. Maarten KoomansContinue reading
dr. Paul van der Nat
prof. dr. Fred van Eenennaam